Navigation Links
Specialty drug costs account for more than 50 percent of the total cost of care for rheumatoid arthritis and hepatitis C patients
Date:4/2/2013

SAN DIEGO, April 2, 2013 /PRNewswire/ -- According to two new studies by Prime Therapeutics (Prime), a leading pharmacy benefit manager, rheumatoid arthritis (RA) and hepatitis C (Hep C) specialty drug costs now make up more than half of the total cost of care for patients with these conditions. Prime will present these studies at the Academy of Managed Care Pharmacy (AMCP)'s 25th Annual Meeting & Expo in San Diego.

"As the pipeline of expensive specialty drugs continues to grow, we need to stay alert to cost of care trends to make sure patients and plan sponsors receive the best value and can manage the increasing cost burden these treatments bring," said Patrick Gleason , PharmD, FCCP, BCPS, director of health outcomes at Prime.

The two studies from Prime, in conjunction with Blue Cross and Blue Shield of Minnesota, evaluated RA and Hep C cost of care trends.

In the first study, researchers found that despite the overall decrease in Hep C specialty drug use from 2008 to 2011 (17.2 percent vs. 14.1 percent), the Hep C specialty pharmacy total cost of care compound annual growth rate (CAGR) was 15 percent from 2008 to 2011. Specialty drug costs accounted for 35 percent ($13,332 of $38,055) of the total cost of Hep C care in 2008 and was substantially higher at 52.6 percent in 2011 ($30,415 of $57,799), with a CAGR of 31.8 percent.

In the second study, researchers found that although RA drug use remained steady from 2008 to 2010 (34.6 percent vs. 35.4 percent), the total cost of care CAGR was 7.3 percent from 2008 to 2010. All other medical costs were $11,252 in 2008 and increased to $13,710 in 2010, with a CAGR of 10.4 percent. Combined RA medical and specialty drug costs accounted for $16,218 (54.7 percent) of $29,652 total cost of care in 2008. In 2010, total cost of care was slightly lower at 53.0 percent ($18,098 of $34,163), with a CAGR of 5.6 percent.

"These studies show the RA and Hep C pharmacy costs now go beyond all medical costs, therefore the expected medical savings cannot offset the specialty drug investment," said Gleason. "As pharmacy benefit managers and health plans strive work to improve the quality of care for individuals with specialty drug needs, the expected increases in cost of care can be lessened through specialty pharmacy management programs. These programs include care management, a limited specialty network, utilization management, and rebate contractual relationships that provide price inflation protection."

Both studies analyzed integrated pharmacy and medical claims from 1.2 million commercially insured, continuously enrolled members receiving a Hep C or RA specialty drug. Among members using these drugs, the average per patient, per year total cost of care was calculated and total cost of care was separated by the following categories: medical specialty drug, medical all other, pharmacy specialty drug and pharmacy all other.

About Blue Cross and Blue Shield of Minnesota
Blue Cross and Blue Shield of Minnesota, with headquarters in the St. Paul suburb of Eagan, was chartered in 1933 as Minnesota's first health plan and continues to carry out its charter mission today as a health company: to promote a wider, more economical and timely availability of health services for the people of Minnesota. Blue Cross is a not-for-profit, taxable organization. Blue Cross and Blue Shield of Minnesota is an independent licensee of the Blue Cross and Blue Shield Association, headquartered in Chicago. Go to bluecrossmn.com to learn more about Blue Cross and Blue Shield of Minnesota.

The Blue Cross and Blue Shield Association is a national federation of 38 independent, community-based and locally operated Blue Cross and Blue Shield companies that collectively provide healthcare coverage for 100 million members – one-in-three Americans. For more information on the Blue Cross and Blue Shield Association and its member companies, please visit www.BCBS.com. We encourage you to connect with us on Facebook, check out our videos on YouTube, follow us on Twitter and check out The BCBS Blog, for up-to-date information about BCBSA

About Prime Therapeutics
Prime Therapeutics LLC (Prime) helps people get the medicine they need to feel better and live well. Prime manages pharmacy benefits for health plans, employers, and government programs including Medicare and Medicaid. The company processes claims and delivers medicine to members, offering clinical services for people with complex medical conditions. Headquartered in St. Paul, Minn., Prime serves nearly 20 million people. It is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Prime has been recognized as one of the fastest-growing private companies in the nation.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Managed Health Care Associates, Inc. (MHA) Announced Erik Halstrom, Vice President of MHA Specialty Pharmacy Solutions, Will Serve on the National Association of Specialty Pharmacy (NASP) Board of Directors
2. Lilavati Hospital, Mumbai Wins Prestigious India Healthcare Awards for Best Multi Specialty Hospital of the Year and No. 1 Metro City Hospital
3. Express Scripts Study Reveals Keys to Controlling Specialty Drug Costs
4. Specialty Practices Find Smoother Path to EHR Adoption and Meaningful Use Certification with Digital Writing Technology from Anoto
5. Society of Interventional Radiology: Pioneering specialty reaches out
6. Managed Health Care Associates, Inc. (MHA) Marks Tenth Anniversary of Hosting Annual Business Summit for Long Term Care, Home Infusion, Home Medical Equipment and Specialty Pharmacies
7. Specialty Pharmacy Association of America (SPAARx) Publishes Definition of Specialty Pharmacy
8. Student Doctor Network Offers New Tools to Help Medical Students Select a Specialty
9. Specialty Pharmacy Association of America (SPAARx) - Enrollment Exceeds 1,000 Members in First Two Weeks since Launch
10. Avella Takes the Mystery Out of Specialty Pharmacies
11. Managed Health Care Associates, Inc. (MHA) Announced as Founding Member Sponsor of The National Association of Specialty Pharmacy (NASP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Intarcia Therapeutics, Inc. today announced the appointment of ... created role of Vice President, Head of Global Medical ... of leadership experience at leading pharmaceutical, biotechnology, and health ... Most recently Dr. Yee served as VP, Head of ... Officer at AstraZeneca, where he led medical affairs across ...
(Date:2/8/2016)... BASEL , Switzerland and PALO ALTO, Calif. ... leader in biological and chemical manufacturing, and Kodiak Sciences ... for the treatment of retinal disease, announced today agreements ... the agreement, Lonza will manufacture material at multiple sites, ... --> --> Retinal ...
(Date:2/8/2016)... 2016 /PRNewswire/--  Cell Applications, Inc. and Cyfuse ... are now available in North America ... bioprinting approach called the "Kenzan Method." Utilizing Cyfuse ... state-of-the-art robotic system that fabricates 3D tissue from ... bio-printing model that makes scaffold-free tissue available immediately ...
Breaking Medicine Technology:
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... Discover the ... visit over 1,400 booths and 700 companies. Attendees also get to see the ... Colorado Garden & Home Show , at the Colorado Convention Center - 700 ...
(Date:2/8/2016)... ... 2016 , ... The Association of Home Care Coding & ... Health and Hospice ICD-10 Transition Workgroup are working closely with the American Hospital ... to address concerns over the use of 'A' as the seventh character indicating ...
(Date:2/8/2016)... Vegas, Nevada (PRWEB) , ... February 08, 2016 ... ... at RowdMap, Inc., will be speaking on how healthcare companies can use newly ... costs, manage the health of a population and intervene and capture the value ...
(Date:2/8/2016)... ... ... The schedule is now online for the largest and most ... being held May 25-29 at the Loews Chicago O’Hare Hotel, continues to give the ... chronic illness in children. , Very recent articles have cited 1 child in 20 ...
(Date:2/7/2016)... Michigan (PRWEB) , ... February 07, 2016 , ... ... organ prolapse with the latest techniques and the most minimally invasive approaches. , ... organ prolapse, particularly after menopause. Other risk factors include surgery to the pelvic ...
Breaking Medicine News(10 mins):